Clinical & Translational Oncology · 2022 · 20 citations · 40 references
MedicineMolecular MedicineOncologyCancer GeneticsMetastasisMolecular OncologyCancer GenomicsCancer Molecular DiagnosticsCancer Molecular PathologyMalignant NeoplasmsMolecular Classification Of TumorsTumor ClassificationCancer Genomics DiagnosticsDiagnostic Follow-upDisease Entity RecognitionGermline Mutation TestingMetastasis PathologyMolecular Medicine IntegrationMolecular Tumor ClassificationTumor Mutation Analysis
Cancer of unknown primary site (CUP) is defined as a heterogeneous group of tumors that appear as metastases, and of which standard diagnostic work-up fails to identify the origin. It is considered a separate entity with a specific biology, and nowadays molecular characteristics and the determination of actionable mutations may be important in a significant group of patients. In this guide, we summarize the diagnostic, therapeutic, and possible new developments in molecular medicine that may help us in the management of this unique disease entity.
40
Joaquı́n Mateo, Debyani Chakravarty, Rodrigo Dienstmann et al. · Annals of Oncology · 2018 · 787 citations · Full text
John D. Hainsworth, Funda Meric‐Bernstam, Charles Swanton et al. · Journal of Clinical Oncology · 2018 · 505 citations · Full text
Medicine, Oncology, Pharmacology +17